Genome-wide association studies (GWAS) have revealed important biological insights into
complex diseases, which are broadly expected to lead to the identification of new drug …

INTRODUCTION The cerebral cortex underlies our complex cognitive capabilities.
Variations in human cortical surface area and thickness are associated with neurological, …

Individuals with complex disorders typically have a heritable burden of common variation that
can be expressed as a polygenic risk score (PRS). While PRS has some predictive utility, it …

The complex aetiology of schizophrenia is postulated to share components with other
psychiatric disorders. We investigated pleiotropy amongst the common variant genomics of …

Pneumonia remains one of the leading causes of death worldwide. In this study, we use
genome-wide meta-analysis of lifetime pneumonia diagnosis (N = 391,044) to identify four …

There is a long-standing interest in exploring the relationship between blood-based
biomarkers and psychiatric disorders, despite their causal role being difficult to resolve in …

Brain morphology differs markedly between individuals with schizophrenia, but the cellular
and genetic basis of this heterogeneity is poorly understood. Here, we sought to determine …

Genetically informed drug development and repurposing is an attractive prospect for
improving patient outcomes in psychiatry; however, the effectiveness of these endeavors is …

While RNA expression appears to be altered in several brain disorders, the constraints of
postmortem analysis make it impractical for well-powered population studies and biomarker …

Signalling by retinoid compounds is vital for embryonic development, with particular importance
for neurogenesis in the human brain. Retinoids, metabolites of vitamin A, exert influence …